I. Introduction
Angiomyofibroblastoma (AMF) is a rare soft-tissue tumor that most frequently affects the lower genital tracts of young to middle-aged women. Angiomyofibroblastoma was first described by Fletcher et al. (1) . This tumor belongs to the group of genital mesenchymal tumors. These tumors commonly involve the vulva, perineum, vagina, uterine cervix (2, 3, 4) but only rarely occur in the pelvis or retroperitoneum and rarely the inguinoscrotal regions of men (5) . The tumors are well circumscribed rarely exceeding more than 12 cm in their greatest dimensions characterized histomorphologically by alternating zones of hypo and hypercellularity and randomly distributed thin walled vessels (6) . No case till date reported of AMF that originated from POD.
II. Case Report
A 44 years old woman presented with intermittent dysuria & UTI since 1 year. Her medical history was unremarkable. Her menstrual cycle was regular, painless and she did not have dysmenorrhoea or menorrhagia. A physical examination didn' t ravel abnormalities. Her ultrasonography (31/01/17) showed large well defined hyper reflected mass measuring 10.3 X 8.3 cm in close relation to the vagina in POD with peripheral vasularity. CT scan (21/03/17) showed a11 X 8.7 X8.8 cm sized heterogeneously enhancing hypodense lesion in the pelvic predominantly in the POD contiguous to the anterior wall of rectum & posterior wall of vagina and the cervix with loss of intervening fat planes. No enlarged lymph nodes were seen in pelvic cavity. MRI scan (21/03/17) showed a sized 9.3 X7.3 X8.6 cm sized heterogeneously enhancing soft tissue tumor with smooth encapsulated margins seen in POD in contiguity with the anterior wall of rectum as well as impinging on the cervix and vagina with moderate mass effect on the adjacent structures. The origin being indeterminate.
The patient was operated on 29/03/2017. Intraop finding shows a soft, regular shaped tumor between the rectum & uterus. It had an intact capsule adhere to or invade the peripheral tissues. Then hysterectomy with complete local excision was carried out. Specimen sent for HPR. The excised tumor was well circumscribed and measured 11 X 8.7 X8.8 cm. The cut surface appeared tan in color and homogeneous with large flesh-like tissue composing of multiple well encapsulated tissues. No hemorrhage, necrosis or cystic changes were observed. Under a microscope, the tumor appeared well demarcated from the surrounding fat tissue was characterized by alternating hyper cellular and hypo cellular edematous zones containing thin walled blood vessels, suggestive of an AMF of POD.
Immunohistochemistry (IHS) revealed that tumor cells were positive for desmin, estrogen receptor (50 %), progesterone receptor (50%). The tumor was negative smooth muscle actin, S -100 Protein, CD 34, CD 117 and B -Catenin. These features indicated a diagnosis of AMF. Post operative USG was normal. Now patient is on closed follow up and long term disease free survival is under assessment.
III. Discussion
AMF is a very rare recently described soft tissues neoplasm with vulva being the most common site of origin. Spermatic cord, urethra and vagina are the other rare sites of occurrence (2, 3, 4] AMF was first described by Fletcher et al. in 1992(1) . . In most reports, AMF has occurred in women aged between 20 and 50 years, i.e., during the reproductive years (1, 2). There are very rare reports of AMF occurring in male patients (5, 8) . They are slowly growing painless masses that are well circumscribed. AMF is benign, soft-tissue tumor that shows myofibroblastic differentiation and represents neoplastic proliferation of stromal cells. Characteristic hypo and hypercellular areas are present with multiple randomly distributed blood vessels with the walls of the blood vessels being thin.(8, 9, 10 ) A perivascular concentration of stromal cells is characteristically seen.
Its cause and pathogenesis are unknown at present. Since AMF is rare, no statistical data are available about its incidence in the general population. Most cases of AMF are benign, and only one case reported by Nielsen et al. reported of sarcomatous transformation in AMF (11) . AMF is an important entity to be recognized, because it requires only simple excision and there are currently no publication reports of local recurrence or metastatic disease when excised complete. Although Weiss et al. mentioned a few cases with recurrence where the tumour was not completely excised (12) . A rare lipomatous variant of AMF with local invasion has also been reported (13, 14) . In most patients, AMF presents as a painless neoplasm located in the superficial regions of the lower female genital tract, such as the vulva and vagina (4), and are therefore easily detected. Tumors in the pelvis, iliac fossa or peritoneal cavity are extremely rare, and usually grow insidiously and reach a massive size before they are detected (14, 15, 16, 17) . Their greatest dimensions have ranged from 3.8 to 25 cm. To our knowledge, only five cases of pelvic AMF have been reported at least so far (Table  1) . Table summarizes the major clinical and pathological features of previously reported cases. In a MEDLINE search terms " Angiomyofibroblastoma," and " Pouch of Douglas," we found no reports of Angiomyofibroblastoma that originating in the Pouch of Douglas. Several reports have analyzed the imaging features of AMFs. On perineal ultrasonography, AMFs appear as a soft-tissue mass with inhomogeneous mixed echogenicity, which corresponds to the cellular inhomogeneity found on histopathological examination. Therefore, the ultrasonographic characteristics of AMFs may help to differentiate them from other mesenchymal neoplasm. On CT imaging, AMFs most likely show moderate-to-strong enhancement, which may reflect the prominent vascularity of these tumors (19) . IHC showed that the tumor expressed estrogen and progesterone receptors, which suggests that it might have originated as a neoplastic proliferation of hormonally responsive mesenchymal cells.
Our chief differential diagnoses were leiomyoma and aggressive angiomyxoma. Aggressive angiomyxoma is most likely to be confused with AMF because it shares many features with AMF including age at presentation, location, clinical manifestations and pathological entities. However, Aggressive angiomyxoma presents as a malignant, locally infiltrative, non-metastasizing stromal neoplasm with a strong tendency to recur. Since the morphology and IHC markers of AMF are similar to those of Aggressive angiomyxoma, differentiation between these two tumors is largely based on the appearance of the tumor margins (AMFs are well demarcated). The treatment of choice for AMF is simple total excision, which is usually curative, and there are almost no incidences of recurrences or metastasis after complete excision, which confirms the benign nature of AMF (20) . AMF shows no propensity for infiltrative growth.
IV. Conclusion
AMF of POD is extremely rare but is benign. a recognition of this entity is important to avoid misdiagnosis of other angiomyxoid neoplasms & leiomyoma. Preoperative diagnosis & differentiation of AMF from other soft tissue tumor are challenging. The combination of radiological data, & histological and IHC findings can confirm the diagnosis. It is important to identity this entity so that the patient can be saved from unnecessary follow up and intervention post excision.
